Etanercept for toxic epidermal necrolysis.
Famularo
Giuseppe
G
Di Dona
Biagio
B
Canzona
Flora
F
Girardelli
Carlo René
CR
Cruciani
Giovanni
G
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002939:Ciprofloxacin / Q000009:adverse effects; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D002939:Ciprofloxacin; D000068800:Etanercept